Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | PGK1 | P00558 | 1/20 | 0.47 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | APP | P05067 | 2/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | F2 | P00734 | 2/20 | 0.43 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | GBA1 | P04062 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6187553 | 0.80 | CYP1A2 (0.51) | RAB9AHTTSMN1; SMN2CYP1A2HRH3 | |
| SCHEMBL6794700 | 0.79 | ALDH1A1 (0.56) | RAB9AHTTSMN1; SMN2CYP1A2HRH3 | |
| SCHEMBL2791730 | 0.75 | ALDH1A1 (0.41) | HTTSMN1; SMN2ALDH1A1LMNAAPP | |
| SCHEMBL6677526 | 0.74 | CYP1A2 (0.69) | RAB9ACYP1A2HRH3ALDH1A1LMNA | |
| SCHEMBL6191801 | 0.74 | RAB9A (0.56) | RAB9AHTTSMN1; SMN2CYP1A2HRH3 | |
| SCHEMBL5652761 | 0.73 | EGFR (0.49) | SMN1; SMN2CYP1A2ALDH1A1LMNAALOX15 | |
| SCHEMBL29736848 | 0.72 | CYP1A2 (0.60) | RAB9AHTTSMN1; SMN2CYP1A2HRH3 | |
| SCHEMBL28731705 | 0.72 | CYP1A2 (0.60) | RAB9AHTTSMN1; SMN2CYP1A2HRH3 | |
| SCHEMBL4842263 | 0.72 | MAOA (0.71) | RAB9AHTTCYP1A2HRH3ALDH1A1 | |
| SCHEMBL264578 | 0.71 | RAB9A (0.59) | RAB9AHTTSMN1; SMN2CYP1A2HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040058903-A1 | Benzamide compounds as apo b secretion inhibitors | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-03-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040058903-A1 | Benzamide compounds as apo b secretion inhibitors | APOB, APOL1, SCARB1 | RAB9A 3707/4885HTT 2566/4885SMN1; SMN2 2504/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.